Brivaracetam
NDC 0121-1074, Brivaracetam, solution, from PAI Holdings, LLC dba PAI Pharma.
- Product NDC
- 0121-1074
- Status
- Listed
- Labeler
- PAI Holdings, LLC dba PAI Pharma
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218494
- DEA schedule
- CV
curl https://api.healthcare.dev/v1/drugs/ndc/0121-1074 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BRIVARACETAM10 mg/mL
Pharmacologic classes
Epoxide Hydrolase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0121-1074-10 | 00121107410 | 1 BOTTLE in 1 CARTON (0121-1074-10) / 300 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/57627ea9-3b14-4428-ad95-6ea25ecaef31NADAC price for package 00121107410
GET /v1/drugs/nadac/00121107410
Use it
Look up 0121-1074 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0121-1074 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0121-1074. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.